One caveat on the spray: Due to the powerful sulfur molecules, the spray is sticky and has a strong odor, but the scent vanishes quickly
neither influenced the content of this publication nor was it involved in the study design, data collection, analysis, interpretation or review
Tirzepatide is a long-acting GLP-1 and GIP receptor agonist that remains active in your body for weeks after injection
The lawsuit, filed Wednesday in Louisiana, focuses on gastroparesis, a severe form of delayed gastric emptying, described by the National Institute of Diabetes and Digestive and Kidney Diseases as a "disorder that slows or stops the movement of food from your stomach to your small intestine." Diabetes is a known cause of gastroparesis, responsible for almost one-third of cases
Tirzepatide should not be combined with other GLP-1 agonists, GIP agonists, or weight-loss medications
Potential for Low Blood Sugar (Hypoglycemia) For individuals with diabetes, the risk of hypoglycemia can increase if semaglutide is absorbed too quickly